Deletion of the NLRP3 gene or pharmacological inhibition of inflammasome formation post-MI is associated with cardiovascular protection resulting in smaller infarct size and better functional recovery [7,13,14,44,82,86,95,96,97,98]. Here, NLRP3 is linked to myocardial infarction.